Literature DB >> 6847282

Transduodenal sphincteroplasty and transampullary septectomy for postcholecystectomy pain.

F G Moody, J M Becker, J R Potts.   

Abstract

Ninety-two patients underwent a transduodenal sphincteroplasty and transampullary septectomy (extended papilloplasty) for chronic, incapacitating upper abdominal pain over an 11-year period. Seventy-nine had a prior cholecystectomy; 42 of 56 patients with reported pathology had documented gallstone disease. Serious morbidity included two moderately severe cases of postoperative pancreatitis and a pulmonary embolus. There were no deaths. Operative findings revealed stenosing papillitis (n = 45), transampullary septitis (n = 40), and papillary dysfunction (n = 7). Histologic examination of septal biopsy specimens revealed inflammation in 34 cases and fibrosis in 19 cases. There were no microscopic abnormalities in 39 biopsy specimens. The results at 1 to 10 years in 83 patients is as follows: good in 36 patients (no pain--43%), fair in 27 patients (occasional pain--33%), and poor in 20 patients (unrelieved by the procedure--24%). Patients with prior sphincteroplasty (12 of 15 with a fair to good result) benefitted the most from the procedure. Those who underwent concomitant cholecystectomy responded poorly. Risk factors for failure include alcoholism, drug addiction, mental illness, and duodenal ulcer disease. The finding of papillary cholesterolosis at operation also was accompanied by a less than optimal result. Transduodenal sphincteroplasty with transampullary septectomy provides long-term benefit to carefully selected patients with chronic abdominal pain after cholecystectomy.

Entities:  

Mesh:

Year:  1983        PMID: 6847282      PMCID: PMC1353049          DOI: 10.1097/00000658-198305000-00017

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  20 in total

1.  Pathological considerations in the choice of operation for chronic relapsing pancreatitis.

Authors:  K W WARREN; M VEIDENHEIMER
Journal:  N Engl J Med       Date:  1962-02-15       Impact factor: 91.245

2.  Treatment of recurrent pancreatitis by transduodenal sphincterotomy and exploration of the pancreatic duct.

Authors:  M K BARTLETT; G L NARDI
Journal:  N Engl J Med       Date:  1960-03-31       Impact factor: 91.245

3.  Pressure measurement in the biliary tract in patients after cholecystolithotomy and in patients with dyskinesia.

Authors:  E DAHL-IVERSEN; A H SORENSEN; E WESTENGAARD
Journal:  Acta Chir Scand       Date:  1958-03-08

4.  Fibrosis of the sphincter of Oddi.

Authors:  R B CATTELL; B P COLCOCK
Journal:  Ann Surg       Date:  1953-06       Impact factor: 12.969

5.  Persistence of symptoms following cholecystectomy with special reference to anomalies of the ampulla of vater.

Authors:  W H COLE; W J GROVE
Journal:  Ann Surg       Date:  1952-07       Impact factor: 12.969

6.  The Nardi test and biliary manometry in the diagnosis of pancreaticobiliary sphincter dysfunction.

Authors:  J A Madura; R L McCammon; J M Paris; J E Jesseph
Journal:  Surgery       Date:  1981-10       Impact factor: 3.982

7.  Papillitis. Inflammatory disease of the ampulla of Vater.

Authors:  J M Acosta; G L Nardi
Journal:  Arch Surg       Date:  1966-03

8.  Papillitis as a cause of pancreatitis and abdominal pain: role of evocative test, operative pancreatography and histologic evaluation.

Authors:  G L Nardi; J M Acosta
Journal:  Ann Surg       Date:  1966-10       Impact factor: 12.969

9.  Gallstone pancreatitis: biliary tract pathology in relation to time of operation.

Authors:  H H Stone; T C Fabian; W E Dunlop
Journal:  Ann Surg       Date:  1981-09       Impact factor: 12.969

10.  Exploration of the pancreatic duct for pancreatitis.

Authors:  M K BARTLETT; W V MCDERMOTT
Journal:  Surg Gynecol Obstet       Date:  1957-03
View more
  17 in total

Review 1.  Pancreatic sphincterotomy and sphincteroplasty.

Authors:  P Watanapa; R C Williamson
Journal:  Gut       Date:  1992-07       Impact factor: 23.059

2.  The morphine-prostigmine provocation (Nardi) test for sphincter of Oddi dysfunction: results in healthy volunteers and in patients before and after transduodenal sphincteroplasty and transampullary septectomy.

Authors:  D N Lobo; A S Takhar; A Thaper; M G Dube; B J Rowlands
Journal:  Gut       Date:  2007-10       Impact factor: 23.059

3.  Monitoring the pressure of the sphincter of Oddi by percutaneous transhepatic choledochoscopy: new method for evaluating motor function.

Authors:  J Kanoh; S Nakazawa; Y Naito; K Inui; Y Tsukamoto
Journal:  Gastroenterol Jpn       Date:  1991-08

4.  Effect of local injection of botulinum toxin on sphincter of Oddi cyclic motility in dogs.

Authors:  H J Wang; M Tanaka; H Konomi; H Toma; K Yokohata; P J Pasricha; A N Kalloo
Journal:  Dig Dis Sci       Date:  1998-04       Impact factor: 3.199

Review 5.  Biliary motility.

Authors:  P A Grace; G J Poston; R C Williamson
Journal:  Gut       Date:  1990-05       Impact factor: 23.059

6.  Clinical and scintigraphic assessment of the role of endoscopic sphincterotomy in the treatment of sphincter of Oddi dysfunction.

Authors:  G M Fullarton; T Hilditch; A Campbell; W R Murray
Journal:  Gut       Date:  1990-02       Impact factor: 23.059

7.  Controlled study of the effect of nicardipine and ceruletide on the sphincter of Oddi.

Authors:  G M Fullarton; S Falconer; A Campbell; W R Murray
Journal:  Gut       Date:  1992-04       Impact factor: 23.059

Review 8.  Certain aspects of normal and abnormal motility of sphincter of Oddi.

Authors:  J C Coelho; F G Moody
Journal:  Dig Dis Sci       Date:  1987-01       Impact factor: 3.199

Review 9.  What is sphincter of Oddi dysfunction?

Authors:  J Toouli
Journal:  Gut       Date:  1989-06       Impact factor: 23.059

10.  Efficacy of nifedipine therapy in patients with sphincter of Oddi dysfunction: a prospective, double-blind, randomized, placebo-controlled, cross over trial.

Authors:  M S Khuroo; S A Zargar; G N Yattoo
Journal:  Br J Clin Pharmacol       Date:  1992-05       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.